Xiaoqin Wang

Dr. Xiaoqin Wang


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 April 2024 in European Journal of Pharmacology
Verified
Journal Article
Open access
JSJiayu Shen
Jiayu Shen
NHNingning Hu
Ningning Hu
ZWZetian Wang
Zetian Wang
LYLina Yang
Lina Yang
RCRujun Chen
Rujun Chen
XWXiaoqin Wang
Xiaoqin Wang
In our previous study, we uncovered that ghrelin promotes angiogenesis in human umbilical vein endothelial cells (HUVECs) in vitro by activating the Jagged1/Notch2/VEGF pathway in preeclampsia (PE). However, the regulatory effects of ghrelin on placental dysfunction in PE are unclear. Therefore, we applied Normal pregnant Sprague-Dawley (SD) rats, treated with lipopolysaccharide (LPS), to establish a PE-like rat model. The hematoxylin-eosin (HE) staining method and immunohistochemistry (IHC) technology were used to detect morphological features of the placenta. IHC and Western blot were applied to examine Bax and Bcl-2 expression levels. The concentrations of serum soluble fms-like tyrosine kinase-1 (sFlt1) and placental growth factor (PIGF) were assessed by enzyme-linked immunosorbent assay (ELISA) kit. In addition, the apoptosis rates of JEG-3 and HTR-8/SVneo trophoblast cells were determined by Annexin V-FITC/PI apoptosis detection kit. Cell migratory capacities were assessed by scratch-wound assay, and RNA-sequencing assay was used to determine the mechanism of ghrelin in regulating trophoblast apoptosis. It has been found that ghrelin significantly reduced blood pressure, urinary protein, and urine creatinine in rats with PE, at the meanwhile, ameliorated placental and fetal injuries. Second, ghrelin clearly inhibited placental Bax expression and circulating sFlt-1 as well as elevated placental Bcl-2 expression and circulating PIGF, restored apoptosis and invasion deficiency of trophoblast cells caused by LPS in vitro. Finally, transcriptomics indicated that nuclear factor kappa B (NF-κB) was the potential downstream pathway of ghrelin. Our findings illustrated that ghrelin supplementation significantly improved LPS-induced PE-like symptoms and adverse pregnancy outcomes in rats by alleviating placental apoptosis and promoting trophoblast migration.

29 January 2025 in Journal of Obstetrics and Gynaecology Canada
Verified
Journal Article
Open access
JYJiani Yuan
Jiani Yuan
DWDuanqing Wu
Duanqing Wu
JYJun Ye
Jun Ye
RCRujun Chen
Rujun Chen
XWXiaoqin Wang
Xiaoqin Wang
LZLiwen Zhang
Liwen Zhang
To investigate the predictive value of soluble FMS-like tyrosine kinase-1 (sFlt-1), coagulation function, and platelet (PLT) parameters for preeclampsia (PE). A prospective study was conducted on women registered and delivered at XXXX Hospital from October 2020 to December 2021. All eligible pregnant women were recruited at the time of initial registration in the first trimester. And we then obtained serum samples uniformly at 24-28 weeks and stored these samples in a freezer at -80°C and labeled them to create a biobank. Later, when PE was diagnosed, we followed the markers to find their blood samples and complete the tests. Participants were divided into healthy pregnant (HP) and PE groups. Participants were divided into healthy pregnant (HP) and PE groups. Approximately 5 mL of venous blood was collected from each participant at 24-28 weeks gestation. Serum sFlt-1 was measured by enzyme-linked immunosorbent assay (ELISA). Additionally, D-dimer (D-D), activated partial thromboplastin time (APTT), thrombin time (TT), prothrombin time (PT), antithrombin III (ATIII), fibrinogen (FIB), PLT, platelet distribution width (PDW), and mean platelet volume (MPV) were recorded. SPSS 27.0 software was used to analyze the correlation of these parameters with PE. Receiver operating characteristic (ROC) curve analysis determined the optimal cutoff value for each parameter. Serum sFlt-1, APTT, TT, ATIII, PLT, MPV, and PDW levels were significantly different between the PE and HP groups (P < 0.05). Among single factor indicators for predicting PE, sFlt-1 exhibited the highest value. With an optimal cutoff value of 4.409 ng/ml, sFlt-1 demonstrated a sensitivity and specificity of 85.4% and 87.5%, respectively. The combination of sFlt-1, APTT, TT, PDW, and MPV yielded the highest predictive value, with an area under the ROC curve (AUC) of 0.946, sensitivity of 86.8%, and specificity of 87.5%. This study demonstrates that a combination of sFlt-1, APTT, TT, PDW, and MPV is a valuable tool for predicting PE.

29 May 2026 in Biomolecules
Verified
Journal Article
Open access
PDF file
ZLZhang Lingling
Zhang Lingling
JYJiani Yuan
Jiani Yuan
NHNingning Hu
Ningning Hu
JYJian Yu
Jian Yu
LZLiwen Zhang
Liwen Zhang
XWXiaoqin Wang
Xiaoqin Wang
Preeclampsia (PE) is a severe pregnancy-specific hypertensive disorder characterized by immune microenvironment dysregulation at the maternal–fetal interface, with decidual macrophage phenotypic imbalance being a key pathological feature. The Ghrelin/growth hormone secretagogue receptor-1a (GHSR-1a) axis exerts immunomodulatory and anti-inflammatory effects, but its role in regulating decidual macrophage infiltration and phenotypic marker expression in PE remains unclear. In this study, we first detected the expression of the Ghrelin/GHSR-1a axis in decidual tissues from 10 healthy pregnant women and 12 PE patients via immunohistochemistry (IHC). We then established a lipopolysaccharide (LPS)-induced PE-like rat model to investigate the axis’s functional role and underlying mechanisms. Intriguingly, clinical analysis revealed a severity-dependent compensatory escalation of the Ghrelin/GHSR-1a axis in PE decidual tissues, potentially representing an endogenous antagonistic response to pregnancy-associated pathological stress. In the animal model, exogenous Ghrelin supplementation reversed LPS-induced PE-like phenotypes, including hypertension, proteinuria, fetal growth restriction (FGR), and placental dysfunction, and alleviated pathological damage to the maternal liver, kidney, and placenta. Mechanistically, Ghrelin modulated decidual macrophage phenotypic marker expression by downregulating the M1 marker CD86 and upregulating the M2 marker CD163 and promoted trophoblast invasion and spiral artery remodeling by restoring laminin, α-cytokeratin 7 (α-CK7), and α-smooth muscle actin (α-SMA) expression in placental tissue. All protective effects of Ghrelin were abrogated by co-administration of D-lys-3-GHRP-6, a specific GHSR-1a antagonist, confirming the dependence on the Ghrelin/GHSR-1a axis. Collectively, our findings suggest that the Ghrelin/GHSR-1a axis is compensatorily upregulated in PE and may exert a protective role by regulating decidual macrophage phenotypic marker expression and improving placental function, providing preliminary evidence that this axis merits further investigation as a potential research target for PE.

10 September 2026 in Tissue and Cell
Verified
Journal Article
Open access
WFWanru Feng
Wanru Feng
XFXinlei Fu
Xinlei Fu
NHNingning Hu
Ningning Hu
RCRujun Chen
Rujun Chen
LZLiwen Zhang
Liwen Zhang
XWXiaoqin Wang
Xiaoqin Wang
Preeclampsia (PE) is a life-threatening complication of pregnancy. Hypoxia-induced mitochondrial damage, oxidative stress and apoptosis in trophoblasts are critical in PE pathogenesis. Ghrelin exerts protective effects in multiple tissues, but its role and mechanism in hypoxic trophoblasts remain unclear. HTR-8/SVneo cells were divided into 8 groups: normoxia, normoxia + 1000 nmol/L D-Lys3-GHRP-6, hypoxia, hypoxia + 1000 nmol/L D-Lys3-GHRP-6, hypoxia + 1, 10, 100, 1000 nmol/L Ghrelin. Mitochondrial ultrastructure was observed by TEM. ROS, MDA, SOD, CAT, GPX4 and apoptosis were detected. Bioinformatics and Western blotting were used to screen and validate proteins. TGFB2 was silenced to verify its mediating role in ghrelin-induced protection. Hypoxia induced mitochondrial swelling, cristae rupture, ROS accumulation, increased MDA, reduced antioxidant enzyme activities and enhanced apoptosis. Ghrelin mitigated these injuriesin a dose-dependent manner, with optimal effect at 1000 nmol/L. Bioinformatics and Western blotting identified TGFB2 as a key target upregulated by hypoxia and downregulated by Ghrelin. TGFB2 knockdown mimicked Ghrelin-mediated protection. Ghrelin protects trophoblasts against hypoxia-induced mitochondrial damage, oxidative stress and apoptosis. This study uncovers a novel mechanism and provides a potential therapeutic target for PE intervention.

1 February 2026 in Translational Cancer Research
Verified
Journal Article
Open access
PDF file
SSShengyan Shen
Shengyan Shen
LZLingling Zhang
Lingling Zhang
QSQiran Sun
Qiran Sun
YHYating Huang
Yating Huang
YYYing Yang
Ying Yang
RCRujun Chen
Rujun Chen
Background: Ovarian cancer is a lethal gynecological malignancy, with ~70% of patients diagnosed at advanced stages (5-year survival <30%) due to suboptimal early detection tools. Current modalities [e.g., carbohydrate antigen 125 (CA125), imaging] lack adequate sensitivity and specificity, while existing machine learning (ML)-based diagnostic models are constrained by small sample sizes and insufficient validation. This study aims to develop and validate a robust ML-based diagnostic model for ovarian cancer using large-scale gene expression data, identify core diagnostic biomarkers, and explore their functional and immune-related mechanisms. Methods: We analyzed five Gene Expression Omnibus (GEO) datasets, with GSE26712, GSE29156, and GSE40595 assigned as the training cohort, and GSE66957 and GSE119054 as independent validation cohorts. Following batch effect correction, 113 ML algorithms were systematically compared. The optimal model was further validated, and its core genes [model gene (Mgenes)] were subjected to functional enrichment and immune cell correlation analyses. Results: The least absolute shrinkage and selection operator (Lasso) + NaiveBayes model demonstrated the strongest diagnostic performance, with area under the receiver operating characteristic curve (AUC) values of 0.991 in the training set, 0.889 in GSE119054, and 0.936 in GSE66957, and achieved 100% recall in both validation cohorts. Twelve Mgenes were identified, among which CP exhibited the highest diagnostic value (AUC =0.966). Functional enrichment revealed that Mgenes were predominantly involved in cell cycle regulation and DNA replication pathways, and correlation analyses confirmed their associations with key immune subsets (e.g., MAOB with regulatory T cells, STAR with CD8+ T cells). Conclusions: The Lasso + NaiveBayes model enables robust ovarian cancer diagnosis, with high recall prioritizing the identification of all potential cases. The identified Mgenes act as both high-performance diagnostic biomarkers and functional mediators of tumorigenesis, laying a foundation for early detection strategies and mechanistic research into ovarian cancer.

18 May 2026 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
NHNingning Hu
Ningning Hu
YYYing Yang
Ying Yang
RCRujun Chen
Rujun Chen
JGJunhua Guan
Junhua Guan
HGHuafen Gu
Huafen Gu
LZLiwen Zhang
Liwen Zhang
Objective: Intrahepatic cholestasis of pregnancy (ICP) is a liver disorder with limited treatment options. This study investigated the therapeutic potential of resveratrol (RES) and its underlying mechanisms, focusing on the gut-liver axis and bile acid metabolism in an estrogen-induced ICP rat model. Methods: Pregnant rats were randomized into Sham, ICP (induced by 17β-estradiol), and ICP+RES (15, 30, 60 mg/kg) groups. Systemic and hepatic inflammation, liver function, histopathology, and intestinal barrier integrity were assessed. Hepatic bile acid profiles were analyzed by UHPLC-MS/MS, and gut microbiota was evaluated by 16S rRNA sequencing. The role of gut microbiota was further examined via fecal microbiota transplantation (FMT) in pseudogerm-free rats. Key proteins in the FXR signaling pathway were analyzed by Western blotting. Results: RES treatment dose-dependently alleviated ICP manifestations, including reducing serum levels of total bile acids, total bilirubin, and liver enzymes (AST, ALT, ALP), while mitigating systemic and hepatic inflammation. It also restored intestinal barrier integrity and corrected gut microbiota dysbiosis. FMT from RES-treated donors recapitulated these therapeutic effects in recipient ICP rats. Furthermore, RES reversed the hepatic bile acid imbalance by reducing primary bile acids and increasing beneficial secondary bile acids. Mechanistically, RES upregulated the expression of FXR and its downstream targets, including SHP, BSEP, UGT2B4, and CYP1A1. Conclusion: RES effectively ameliorated ICP through multi-faceted mechanisms involving the attenuation of inflammation, restoration of gut microbiota and intestinal barrier, and correction of bile acid homeostasis via activation of the FXR signaling pathway. Our findings highlight RES as a promising multi-mechanistic therapeutic candidate for ICP.